Novartis shares slip after mixed heart drug data

ZURICH, Aug 28 (Reuters) – Investors shrugged off Novartis’soptimism that its new anti-inflammatory drug will makeinroads into treating heart-attack survivors and sent its shareslower on Monday as some experts called new data unconvincing.
The post Novartis shares slip after mixed heart drug data appeared first on RocketNews | Top News Stories From Around the Globe.